93 related articles for article (PubMed ID: 9204057)
1. Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study.
Zonneveld IM; Meinardi MM; Karlsmark T; Johansen UB; Kuiters GR; Hamminga L; Staberg B; van't Veen AJ; Bossuyt PM; van Niel JC; Bos JD
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):932-4. PubMed ID: 9204057
[TBL] [Abstract][Full Text] [Related]
2. Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial.
Kristensen JK; Petersen LJ; Hansen U; Nielsen H; Skov PS; Nielsen HJ
Br J Dermatol; 1995 Dec; 133(6):905-8. PubMed ID: 8547042
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of ranitidine in psoriasis. An open prospective study].
Nielsen HJ; Kristensen JK; Hansen U; Nielsen HI; Skov PS; Petersen LM
Ugeskr Laeger; 1997 Jan; 159(5):598-600. PubMed ID: 9045450
[TBL] [Abstract][Full Text] [Related]
4. High-dose ranitidine is ineffective in the treatment of psoriasis.
Cetin L; Yilmaz E; Alpsoy E; Başaran E
Br J Dermatol; 1997 Dec; 137(6):1021-2. PubMed ID: 9470934
[No Abstract] [Full Text] [Related]
5. Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid.
Hegarty JH; Halvorsen L; Hazenberg BP; Nowak A; Smith CL; Thomson AB; Vantrappen G; McKenna CJ; Mills JG
Can J Gastroenterol; 1997; 11(1):83-8. PubMed ID: 9113805
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine as adjuvant treatment in colorectal cancer.
Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
8. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
9. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine improves lymphocyte function after severe head injury: results of a randomized, double-blind study.
Rixen D; Livingston DH; Loder P; Denny TN
Crit Care Med; 1996 Nov; 24(11):1787-92. PubMed ID: 8917026
[TBL] [Abstract][Full Text] [Related]
11. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine.
Petersen LJ; Hansen U; Kristensen JK; Nielsen H; Skov PS; Nielsen HJ
Acta Derm Venereol; 1998 May; 78(3):190-3. PubMed ID: 9602224
[TBL] [Abstract][Full Text] [Related]
12. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H; van de Kerkhof PC; Strohal R; Kubanov A; Valenzuela F; Lee JH; Yakusevich V; Chimenti S; Papacharalambous J; Proulx J; Gupta P; Tan H; Tawadrous M; Valdez H; Wolk R;
Lancet; 2015 Aug; 386(9993):552-61. PubMed ID: 26051365
[TBL] [Abstract][Full Text] [Related]
14. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests.
Kupczyk M; Kupryś I; Bocheńska-Marciniak M; Górski P; Kuna P
Allergy Asthma Proc; 2007; 28(6):711-5. PubMed ID: 18201437
[TBL] [Abstract][Full Text] [Related]
16. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
19. Placebo controlled studies with ranitidine in duodenal ulcer.
Dobrilla G; Barbara L; Bianchi Porro G; Felder M; Mazzacca G; Miglioli L; Pera A; Petrillo M; Sabbatini F; Verme G
Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.
Farup PG; Wetterhus S; Osnes M; Ulshagen K
Scand J Gastroenterol; 1997 Aug; 32(8):755-9. PubMed ID: 9282965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
